Abstract 3027: Cellular uptake of nanoliposomes with optimized cholesterol concentration and lipid extract derived from a model low grade serous ovarian carcinoma cell line

Abstract Introduction: Low-grade serous ovarian carcinoma (LGSOC) represents a rare subtype of epithelial ovarian cancer, accounting for less than 10% of all cases and typically diagnosed in younger women. The disease is characterized by tumor growth driven by activating mutations in the MAPK pathway, including KRAS, BRAF, and NRAS. Despite its slow progression, LGSOC remains challenging to treat due to limited responsiveness to conventional chemotherapy. The objective of this study was to isolate cellular lipid extract (LE) material from a model LGSOC cell line, and to utilize the newly acquired LE material to develop a relatively target specific nanoliposomal system. Early formulation and in vitro studies include optimization for cholesterol and LE content. Methods: Low-grade serous ovarian carcinoma cell line (PM-LGSOC-01, Cytion) was cultured and expanded in EMEM growth medium supplemented with 10% FBS. The PM-LGSOC-01-lipid extract (LE) material was extracted from PM-LGSOC-01 when the cells reached ∼90% confluency. Lipid extraction was performed as described previously (Alharbi & Campbell, AAPS Open, number: 5(2018)). Nanoliposomal preparations consisted of DOPC, cholesterol, and LE at various ratios and wereformed by thin film method using a Buchi R-80 rotary evaporator. DPPE-Rhodamine was included in the preparations for cellular studies. Following sonication, particle size and zeta potential values weredetermined using ZetaPals. Fluorescence detection was performed using a fluorescence microplate reader. Results: Three preparations (1) DOPC (100%), (2) DOPC/Chol (95/5), and (3) DOPC/Chol (90/10) wereprepared with an average particle size of 221 ± 3 nm, 250 ± 5 nm, and 139 ± 0.3 nm, respectively. Preliminary results suggest that the additional inclusion of cholesterol in the nanoliposomal preparations increased their uptake by the target (PM-LGSOC-01) cells. Studies investigating the influence of PM-LGSOC-01-LE on the uptake of nanoliposomes by the target cells are currently underway. Conclusion: To date, the influence of cholesterol on the uptake of nanoliposomes by LGSOC cells has been investigated. Future studies will evaluate the effect of optimized cholesterol and LE contenton targeting low-grade serous ovarian carcinoma. Citation Format: Sofia Orlando, Krishna Panchal, Heer Patel, Robert B. Campbell. Cellular uptake of nanoliposomes with optimized cholesterol concentration and lipid extract derived from a model low grade serous ovarian carcinoma cell line [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3027.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-3027
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 3027: Cellular uptake of nanoliposomes with optimized cholesterol concentration and lipid extract derived from a model low grade serous ovarian carcinoma cell line

Sofia Orlando, Krishna Panchal, R. B. Campbell, Heer Patel
Cancer Research
Extracellular vesicles in disease
article

Abstract 3027: Cellular uptake of nanoliposomes with optimized cholesterol concentration and lipid extract derived from a model low grade serous ovarian carcinoma cell line

Sofia Orlando, Krishna Panchal, R. B. Campbell, Heer Patel
article en

Abstract

Abstract Introduction: Low-grade serous ovarian carcinoma (LGSOC) represents a rare subtype of epithelial ovarian cancer, accounting for less than 10% of all cases and typically diagnosed in younger women. The disease is characterized by tumor growth driven by activating mutations in the MAPK pathway, including KRAS, BRAF, and NRAS. Despite its slow progression, LGSOC remains challenging to treat due to limited responsiveness to conventional chemotherapy. The objective of this study was to isolate cellular lipid extract (LE) material from a model LGSOC cell line, and to utilize the newly acquired LE material to develop a relatively target specific nanoliposomal system. Early formulation and in vitro studies include optimization for cholesterol and LE content. Methods: Low-grade serous ovarian carcinoma cell line (PM-LGSOC-01, Cytion) was cultured and expanded in EMEM growth medium supplemented with 10% FBS. The PM-LGSOC-01-lipid extract (LE) material was extracted from PM-LGSOC-01 when the cells reached ∼90% confluency. Lipid extraction was performed as described previously (Alharbi & Campbell, AAPS Open, number: 5(2018)). Nanoliposomal preparations consisted of DOPC, cholesterol, and LE at various ratios and wereformed by thin film method using a Buchi R-80 rotary evaporator. DPPE-Rhodamine was included in the preparations for cellular studies. Following sonication, particle size and zeta potential values weredetermined using ZetaPals. Fluorescence detection was performed using a fluorescence microplate reader. Results: Three preparations (1) DOPC (100%), (2) DOPC/Chol (95/5), and (3) DOPC/Chol (90/10) wereprepared with an average particle size of 221 ± 3 nm, 250 ± 5 nm, and 139 ± 0.3 nm, respectively. Preliminary results suggest that the additional inclusion of cholesterol in the nanoliposomal preparations increased their uptake by the target (PM-LGSOC-01) cells. Studies investigating the influence of PM-LGSOC-01-LE on the uptake of nanoliposomes by the target cells are currently underway. Conclusion: To date, the influence of cholesterol on the uptake of nanoliposomes by LGSOC cells has been investigated. Future studies will evaluate the effect of optimized cholesterol and LE contenton targeting low-grade serous ovarian carcinoma. Citation Format: Sofia Orlando, Krishna Panchal, Heer Patel, Robert B. Campbell. Cellular uptake of nanoliposomes with optimized cholesterol concentration and lipid extract derived from a model low grade serous ovarian carcinoma cell line [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3027.

Cancer ResearchVol. 86(7_Supplement)
Massachusetts College of Pharmacy and Health Sciences (US)
Good health and well-being
Openalex Percentile: Top 7%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.